YS BIOPHARMA CO LTD (YS)

KYG9845F1090 - Common Stock

0.7199  +0.01 (+1.39%)

After market: 0.7055 -0.01 (-2%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-3-31)
2022
(2021-12-31)
2021
(2020-12-31)
2020
(2020-12-31)
Revenue
687.20M0.000.000.00
Cost Of Goods
153.36M117.07MN/AN/A
Gross Profit
533.84M385.88MN/AN/A
Operating Expenses
673.22M556.83K3.64K3.64K
Research and Development
318.70M211.22MN/AN/A
Selling, General, and Administrative Expenses
354.52M549.18K549.18KN/A
Operating Income
-139.38M-556.83K-3.64K-3.64K
Interest Income/Expense
-30.86M-3.28M-3.28MN/A
Other Income/Expense
25.89M3.29M3.29MN/A
Non Recurring Items
N/A0.000.00N/A
Income Before Taxes
-144.35M-545.73K-3.64K-3.64K
Income Tax
1.13M4.94MN/AN/A
Net Income
-283.47M-545.73K-3.64K-3.64K
EBITDA
-102.69M30.60MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-3.05-0.03-0.00-0.00
 
Statistics
Gross Profit Margin
77.68%N/AN/AN/A
Profit Margin
-41.25%N/AN/AN/A
Operating Profit Margin
-20.28%N/AN/AN/A

All data in CNY

Charts